Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

The document explains various skin conditions and their treatments.

Lowering testosterone speeds up wound healing in male mice.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Iron deficiency can cause hair abnormalities, but taking iron can fix them and stop hair loss.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Minoxidil works in liver and outer hair root sheath for hair growth.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Prolactin may affect hair growth differently based on gender and scalp area.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.